Similar articles for PMID: 28068801

Year	Number of Results
1990	1
1995	1
1997	1
1998	1
1999	1
2004	2
2006	1
2007	3
2008	2
2009	1
2010	1
2011	1
2012	4
2013	3
2014	6
2015	13
2016	17
2017	16
2018	12
2019	17
2020	13
2021	11
2022	17
2023	7
2024	1

1

The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.

Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B. Wilkinson MJ, et al. Angiology. 2017 Oct;68(9):795-798. doi: 10.1177/0003319716688415. Epub 2017 Jan 10. Angiology. 2017. PMID: 28068801

2

Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.

Capoulade R, Yeang C, Chan KL, Pibarot P, Tsimikas S. Capoulade R, et al. JAMA Cardiol. 2018 Dec 1;3(12):1212-1217. doi: 10.1001/jamacardio.2018.3798. JAMA Cardiol. 2018. PMID: 30476957 Free PMC article. Clinical Trial.

3

Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.

Nsaibia MJ, Mahmut A, Boulanger MC, Arsenault BJ, Bouchareb R, Simard S, Witztum JL, Clavel MA, Pibarot P, Bossé Y, Tsimikas S, Mathieu P. Nsaibia MJ, et al. J Intern Med. 2016 Nov;280(5):509-517. doi: 10.1111/joim.12519. Epub 2016 May 30. J Intern Med. 2016. PMID: 27237700 Free article.

4

Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.

Capoulade R, Chan KL, Mathieu P, Bossé Y, Dumesnil JG, Tam JW, Teo KK, Yang X, Witztum JL, Arsenault BJ, Després JP, Pibarot P, Tsimikas S. Capoulade R, et al. Atherosclerosis. 2017 May;260:1-7. doi: 10.1016/j.atherosclerosis.2017.03.013. Epub 2017 Mar 9. Atherosclerosis. 2017. PMID: 28319871 Clinical Trial.

5

Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.

Perrot N, Thériault S, Dina C, Chen HY, Boekholdt SM, Rigade S, Després AA, Poulin A, Capoulade R, Le Tourneau T, Messika-Zeitoun D, Trottier M, Tessier M, Guimond J, Nadeau M, Engert JC, Khaw KT, Wareham NJ, Dweck MR, Mathieu P, Pibarot P, Schott JJ, Thanassoulis G, Clavel MA, Bossé Y, Arsenault BJ. Perrot N, et al. JAMA Cardiol. 2019 Jul 1;4(7):620-627. doi: 10.1001/jamacardio.2019.1581. JAMA Cardiol. 2019. PMID: 31141105 Free PMC article.

6

Plasma Lipoprotein(a) measured in routine clinical care and the association with incident calcified aortic valve stenosis during a 14-year observational period.

Wodaje T, Littmann K, Häbel H, Bottai M, Bäck M, Parini P, Brinck J. Wodaje T, et al. Atherosclerosis. 2022 May;349:175-182. doi: 10.1016/j.atherosclerosis.2022.02.016. Epub 2022 Feb 28. Atherosclerosis. 2022. PMID: 35277251

7

Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.

Ma GS, Wilkinson MJ, Reeves RR, Yeang C, DeMaria AN, Cotter B, Patel M, Mahmud E, Tsimikas S. Ma GS, et al. Angiology. 2019 Apr;70(4):332-336. doi: 10.1177/0003319719826461. Epub 2019 Jan 30. Angiology. 2019. PMID: 30700108

8

Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.

Perrot N, Thériault S, Rigade S, Chen HY, Dina C, Martinsson A, Boekholdt SM, Capoulade R, Le Tourneau T, Messika-Zeitoun D, Engert JC, Wareham NJ, Clavel MA, Pibarot P, Smith JG, Schott JJ, Mathieu P, Bossé Y, Thanassoulis G, Arsenault BJ. Perrot N, et al. Heart. 2020 Sep;106(18):1407-1412. doi: 10.1136/heartjnl-2020-316722. Epub 2020 Jul 7. Heart. 2020. PMID: 32636298

9

The current landscape of lipoprotein(a) in calcific aortic valvular disease.

Hsieh G, Rizk T, Berman AN, Biery DW, Blankstein R. Hsieh G, et al. Curr Opin Cardiol. 2021 Sep 1;36(5):542-548. doi: 10.1097/HCO.0000000000000901. Curr Opin Cardiol. 2021. PMID: 34397461 Free PMC article. Review.

10

Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.

Vuorio A, Watts GF, Kovanen PT. Vuorio A, et al. Atherosclerosis. 2019 Feb;281:25-30. doi: 10.1016/j.atherosclerosis.2018.11.040. Epub 2018 Dec 7. Atherosclerosis. 2019. PMID: 30616181 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year